![Joseph Lasaga](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joseph Lasaga
Corporate Officer/Principal presso RIGEL PHARMACEUTICALS, INC.
Posizioni attive di Joseph Lasaga
Società | Posizione | Inizio | Fine |
---|---|---|---|
RIGEL PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/1998 | - |
Storia della carriera di Joseph Lasaga
Precedenti posizioni note di Joseph Lasaga
Società | Posizione | Inizio | Fine |
---|---|---|---|
Galena Biopharma, Inc.
![]() Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Corporate Officer/Principal | 01/12/2014 | 01/10/2016 |
NEKTAR THERAPEUTICS | Corporate Officer/Principal | 01/01/2012 | 01/08/2014 |
Formazione di Joseph Lasaga
San Francisco State University | Masters Business Admin |
San Jose State University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Posizioni
Corporate Officer/Principal | 3 |
Masters Business Admin | 1 |
Undergraduate Degree | 1 |
Settori
Health Technology | 4 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
RIGEL PHARMACEUTICALS, INC. | Health Technology |
NEKTAR THERAPEUTICS | Health Technology |
Aziende private | 1 |
---|---|
Galena Biopharma, Inc.
![]() Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Health Technology |
- Borsa valori
- Insiders
- Joseph Lasaga
- Esperienza